/Investor DB

Mitsui Global Investment — Full Portfolio

62 tracked investments · listed companies and verified rows first

Kalturakaltura.comin𝕏NASDAQ: KLTRNov 2012 · $25M

Kaltura provides AI-powered video platforms for live and on-demand digital experiences that enable brands and organizations to engage audiences and achieve business goals.

AI & Machine LearningEnterprise SoftwareMedia & EntertainmentNew York, US

Ron Yekutiel(Founder)inShay David(Director)inEynav Azaria(Chief Product, Engineering and Marketing Officer)inNatan Israeli(Chief Customer and Commercial Officer)inMichal Tsur(Founder)in

Co-investors.406 VenturesAvalon Ventures Management, LlcLuminari CapitalNGP CapitalRuna CapitalSapphire Ventures+5 more

Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalPivotal Life SciencesSolasta Ventures+2 more

Valens (NYSE: VLN)valens.comin𝕏NYSE: VLN

Valens develops high-performance connectivity chipsets that are embedded in devices to support digital and connectivity experiences.

Deep TechHardwareMobility & TransportationSemiconductors

Co-investors10DAmiti VenturesAviv Venture CapitalF4 VenturesMagenta Venture PartnersMagma Venture Partners+3 more

Actimis Pharmaceuticals IncinMar 2017Acquired

Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.

BiotechSan Mateo, US

Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)in

BoardFred Middleton(Director)Masaji Matsuoka(Director)in

ARMAGEN TECHNOLOGIES, INC.armagen.comAcquired

Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.

Ruben Boado(Founder)in

Co-investorsBoehringer Ingelheim Venture Fund

Autotalksauto-talks.com

Israeli fabless semiconductor company making vehicle-to-everything (V2X) communication chipsets for connected and autonomous vehicles.

Co-investorsAmiti VenturesFraser McCombs CapitalMagenta Venture PartnersMagma Venture PartnersManiv MobilitySamsung Catalyst Fund+6 more

Ellipsisellipsis.devin𝕏

Ellipsis builds AI agents that handle repetitive engineering tasks like code review, production debugging, and standup reports, letting teams focus on higher-value work.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US

Hunter Brooks(CEO)inNick Bradford(CTO)

Co-investorsPioneerTranspose Platform ManagementY CombinatorAmino CapitalCRV (Charles River Ventures)Four Cities+5 more

Ellipsis Healthellipsishealth.comin𝕏Jun 2025

Ellipsis Health builds Sage, an AI voice agent designed to support healthcare organizations by handling patient interactions and expanding clinical capacity.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Mainul Islam(Executive Officer, Director)Mainul Mondal(Founder)inMichael Aratow(Co-Founder & Chief Medical Officer)in

BoardMarie Hurabiell(Director)

Co-investorsAble PartnersAIX VenturesAlumni VenturesAwareness VentureCity LightCVS Health Ventures+10 more

GoSecure, Inc.gosecure.ai

GoSecure is a Managed Detection and Response (MDR) cybersecurity provider based in Montreal and San Diego.

San Diego, US

Co-investorsEastward Capital PartnersRazor's Edge VenturesShield CapitalYaletown Partners

Mahzi Therapeuticsmahzi.com

Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.

BiotechHealthtechSouth San Francisco, US

Yael Weiss(Chief Executive Officer)in

BoardCamille Samuels(Director)inMarten Steen(Director)inShalini Sharp(Director)inStephen Farr(Director)

Co-investorsDroia VenturesHBM Healthcare InvestmentsHBM PartnersHealthCapVenrock

Marrone Bio InnovationsinAug 2015Acquired

Davis, California developer of biological crop protection, plant health and waterway treatment products, formerly NASDAQ: MBII.

AgTechDavis, US

Pamela G. Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Linda V. Moore(Executive Officer)inDon Glidewell(Executive Officer)inJulie I Morris(Executive Officer)inChris Hildreth(Executive Officer)in

Co-investorsBand of AngelsPoint Financial Capital

MC10mc10inc.comin𝕏acquired by Medidata

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

BiotechDigital HealthHealthtechMedical DevicesLexington, US

John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)

BoardMarc Singer(Director)in

Co-investorsBraemar Energy VenturesOUP (Osage University Partners)Windham Capital PartnersAberdare VenturesNorth Bridge Venture Partners & Growth Equity

Neura Healthneurahealth.coin

Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.

Digital HealthHealthtechNew York, US

Sameer Madan(Founder)inElizabeth Burstein(Founder)in

Co-investorsCorrelation VenturesE12 Venture Capital, LlcEsplanade VenturesKoch Disruptive TechnologiesNext Play VenturesPear VC+5 more

OpenXopenx.cominFeb 2012

OpenX is a supply-side platform (SSP) for digital advertising that uses AI, data leadership, and proprietary identity technology to manage ad inventory and targeting.

AdTechAI & Machine LearningNot specified on page, US

DAMON REEVE(Director)inTIM CADOGAN(Executive Officer, Director)inJoshua Metzger(Interim CEO)in

BoardNINO MARAKOVIC(Director)inANDREW Scott BRACCIA(Director)BERNARD DALLE(Director)in

Co-investorsChartline Capital PartnersDag VenturesIndex VenturesLocalGlobePresidio VenturesSapphire Ventures+7 more

Pica8pica8.orgSep 2014

Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.

Palo Alto, US

Chunyi (James) Liao(Executive Officer, Director)

BoardTerry Chen(Director)inChen-Wen Tarn(Director)Mike Splinter(Director)

Co-investorsVantagePoint Capital PartnersWI Harper Group

ProteinSimpleproteinsimple.comAcquired

ProteinSimple developed instruments and consumables for protein analysis; acquired by Techne/Bio-Techne for $300M in 2014.

Co-investorsLatterell Venture PartnersThe Vertical Group

Proterraproterra.com

Proterra designs and manufactures zero-emission battery systems for commercial vehicles.

CleantechHardwareMobility & TransportationGreenville, US

Ryan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)C. W. Plummer, Jr.(Executive Officer)Dave Rich(Executive Officer)Christopher BaileyinDale Hill(Founder)

Co-investorsBMW i VenturesConductive VenturesConstellation Technology VenturesEnergy Impact PartnersEvolution VC PartnersObvious Ventures+6 more

QD Laserqdlaser.com

QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.

Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP

Mitsuru Sugawara(Founder)in菅原 充(Founder & Chief Technology Advisor)大久保 潔(President & Representative Director)

Co-investorsBeyond Next VenturesDG Ventures, Inc.MIRAI SOUZOUNTT DOCOMO VenturesOita Venture CapitalSMBC Venture Capital+5 more

Quralisquralis.comin𝕏Mar 2023

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more

Reunion Neurosciencereunionneuro.comin𝕏

Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.

BiotechDigital HealthMental HealthMorristown, US

Sahil V. Kirpekar(President and CEO)inGregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in

Co-investorsFemHealth VenturesMPM BioImpactPalo Santo VCNovo Holdings

Rhinorhino.aiinDec 2024

Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US

Adam Branch(Executive Officer, Director, Promoter)in

BoardHarrison Touati(Director)Jon Galitzer(Director)

Co-investorsKoch Disruptive TechnologiesLionBirdAlleyCorpArkin Digital HealthGaingelsJLL Spark Global Ventures+3 more

Rhino Federated Computingrhinofcp.comin

Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.

AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US

Ittai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)

BoardEdward Michael(Director)inIvneet Bhullar(Director)in

Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMana VenturesQiming Venture Partners USA+6 more

Rive Technologyrivetechnology.cominOct 2015

Monmouth Junction, US

David C. Aldous(Executive Officer, Director)in

BoardWilliam Wiberg(Director)Jamie Kiggen(Director)Daniel Carter(Director)inMichael Zak(Director)David J. Tippeconnic(Director)

Co-investorsHercules Capital, Inc.Aramco VenturesSaudi Aramco Energy VenturesThe Blackstone Group

Ruckus Wireless, Inc.jscom.jp𝕏Feb 2012Acquired

JS Communications provides network integration services, infrastructure solutions, and security technologies for enterprise IT systems.

Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareIoTTokyo, JP

William Kish(Executive Officer, Director)Victor Shtrom(Executive Officer)Selina Lo(Executive Officer, Director)James Hennessy(Executive Officer)愛須 康之(代表取締役会長 (Representative Director & Chairman))渡邉 辰夫(代表取締役社長 (Representative Director & President))

Co-investorsMobile Internet Capital, Inc.WingSequoia CapitalSutter Hill Ventures

Sirrussirruschemistry.cominAcquired

Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.

Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US

Bernard Malofsky(Executive Officer)inJeff Uhrig(President, Chief Executive Officer, Secretary and Treasurer)inRobert Smith(Executive Officer)Adam Malofsky(Director)

BoardWilliam Lese(Director)inDoug Cameron(Director)

Co-investorsBraemar Energy VenturesCincyTechArsenal

Spire Globalspire.comin𝕏

Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.

Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US

Peter Platzer(Executive Chairman)inJeroen Cappaert(Founder)inJoel Spark(Founder)inTheresa Condor(Chief Executive Officer)inCelia Perez Pelaz(Executive Officer)Thomas Krywe(Executive Officer)in

Co-investorsBessemer Venture PartnersBright Success CapitalEvolution VC PartnersExpon CapitalFresco CapitalGen Capital+12 more

Stately Biostatelybio.cominMay 2025

Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.

AI & Machine LearningBiotechMedical Devices

Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)

Co-investorsAIX VenturesFoothill VenturesAxial VCBoxOne VenturesCaffeinated CapitalDimension Capital+1 more

Svantesvanteinc.comin𝕏

Svante builds filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and directly from the air.

CleantechClimate TechDeep TechEnergyNew MaterialsBurnaby, CA

Matthew Stevenson(Executive Officer)inClaude Letourneau(President & CEO)

BoardMarc Van Den Berg(Director)Roger Strauch(Director)inDamien Vacherot(Director)Laura Boudreau(Director)

Co-investorsChrysalixThe Roda GroupChevron Technology VenturesMitsui & CoTemasekBay Bridge Ventures Climate+7 more

TACIT THERAPEUTICStacittx.comin

Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.

BiotechDeep TechHealthtechSan Francisco, US

Co-investorsCivilization Ventures Management, LlcEisai Innovation, Inc.KdT VenturesLaurier Startup FundMichigan Capital Network

Therini Biotherinibio.comin

Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.

BiotechDigital HealthHealthtechMedical DevicesSacramento, US

Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in

BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)

Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundDolby Family Ventures+2 more

Waypoint Biowaypointbio.comin𝕏

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep TechNew York, US

Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in

Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalRecode VenturesVillage Global+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ActimisArmaGenBeceemBioelectron Technology CorpBionova Pharmaceuticals LimitedBoston Biomedical IncChange Healthcare CorpCipiaContinuumrx ServicesConvenient Power LimitedEnsemEtonenet IncGladd Inc Fka Glamour Sales Holding LtdGobalto IncHainan Hailing Pharmaceutical LimitedHalationIat Automobile TechnologyLeash LaboratoriesLeyou IncNapaJen Pharma, Inc.NvascNxthera IncOn Chip BiotechnologiesPinnacle EnginesRedwood Systems IncS*BIOSbio Pte LtdSilk Fka Kaminario IncSix Rooms HoldingsSymic BiomedicalVirident

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.